Answer: BPC-157 has been studied most for gut and inflammatory bowel conditions, wound and tissue repair, tendon and joint recovery, collagen support for skin, and systemic inflammation, though much of this evidence is preclinical
There's limited evidence that doses above 600mcg provide additional benefit
Visceral fat is strongly associated with increased cardiovascular disease risk, and its reduction typically correlates with improved cardiovascular health markers
It is a regenerative peptide that support healing, recovery, and inflammation reduction, making weight loss easier and more sustainable
Building familiarity with both options provides flexibility to adapt your approach as situations change
2) Pro-angiogenic Signaling via VEGFR2 Akt eNOS In cellular and animal models, BPC-157 increased endothelial tube formation and improved blood-flow recovery after hind-limb ischemia